BioPortfolio Bulletin

  http://www.bioportfolio.com/bulletin_27.htm                          November 18 2003

Sponsor

British Pharmacopoeia 2003: legally enforceable deadline approaches. From 1^st December, your 2002 edition of the British Pharmacopoeia becomes obsolete. The 2003 edition is the only authoritative collection of legal standards and reference material for researchers, developers and manufacturers of medicinal substances within the UK. Available in book and CD-Rom format, the British Pharmacopoeia 2003 ensures legal compliance. Order now for confident compliance. 
Click here to buy your copy now: [http://www.tso.co.uk/bookshop/bookstore.asp?DI=510404]

Interested in advertising on BioPortfolio? - please review:
http://www.bioportfolio.com/advertis/advantag.htm 

The Cardiovascular Market Outlook to 2008, is a comprehensive source of market analysis of the most valuable therapy area within the global pharmaceutical market. Valued at an estimated $73.7bn in 2002, the global market for cardiovascular drugs grew by a moderate 2.5% over 2001 levels. But how much do you know about the fastest growing cardiovascular (CV) segment? Who has the fastest growing CV portfolio? And how will the market develop in the next five years? All these questions and more are answered in this new management report.

This report provides detailed analysis of patient pool potential, sub-markets, leading companies' strategies, key industry developments and potential CV blockbusters of the future. With this analysis you will be able to identify areas for investment and develop strategies to counter any upcoming threats to your CV drug portfolio.

Lifecycle management strategies are also becoming as important as product innovation in maintaining and building market shares and revenues. Understand how leading companies are maximizing lifecycle management strategies to extend revenue streams within the cardiovascular market with this new report.

Top five reasons to buy this report...

• Analyze the recent performance of drugs in each therapeutic class of the global cardiovascular market.
• Understand how the competitive landscape may be changed by the results of clinical trials such as CURE, LIFE, ALLHAT and HOPE.
• Assess the strength of leading players' cardiovascular portfolios and identify how they are positioning themselves to maintain and build franchise revenues.
• Quantify your products' market potential in the cardiovascular market by evaluating the patient base in different therapeutic classes.
• Benchmark the performance and potential of future cardiovascular blockbuster drugs from compounds currently in development, including third generation statins, new anti-hypertensives and an oral anti-coagulant.

As a special offer in November we are offering you the chance to receive “The Pharmaceutical Portfolio Management Outlook” For free when you order “The Cardiovascular Market Outlook to 2008” $1199.00

Place your order before 30th November to receive your free report email peter.barfoot@bioportfolio.com today or order online at: 
http://www.bioportfolio.com/cgi-bin/acatalog/Reuters_2003.html

By using BioPortfolio's BioNewsCast service you will obtain rapid global distribution through Moreover.com's biotechnology and pharmaceutical newsfeeds used by thousands of web sites including the lead search engines Yahoo, MSN, Ask Jeeves; BioPortfolio's BioNews Search Engine and hundreds of press editors and millions of internet users...more!
http://www.bioportfolio.com/advertis/biopcast.htm

Register a new job seeker account and submit a resume or CV to become eligible for the drawing. Please note, you must enter a resume or CV.

For our Employers and Recruiters, submit a NO CHARGE Premium Job Listing!
All job listings submitted to BioPortfolio will appear on all network career centers for 60 days. Network pricing is $100 USD per Standard Job Listing and $125 USD per Premium Job Listing. Register a new Employer Account on BioPortfolio to receive your first Premium Job Listing at no charge.

To take advantage of this promotion, visit the BioPortfolio Employer Page at: www.biojobnetwork.net/BioPortfolio/T/Employer. 

Register a new account and enter this Promotional Code upon login to your account: HD9C2Y . Then, create and submit your job listing(s). This offer is valid through November 30, 2003.

• LeadDiscovery
• Drug and Market Development
• Drug and Market Development Guides
• Visiongain
• Reuters Business Insight
• Urch Publishing
• BioSeeker
• Cambridge Healthtech Institute
• AS Insights
• Datamonitor Biotechnology Reports
• Datamonitor Cardiovascular Reports
• Datamonitor CNS Central Nervous System Reports
• Datamonitor Drug Delivery Reports
• Datamonitor Drug Discovery Reports
• Datamonitor eHealthcare Pharma Reports
• Datamonitor Immune Disorders and Inflammation Rep.
• Datamonitor Infectious Diseases Reports
• Datamonitor Market and Sales Reports
• Datamonitor Medical Devices Reports
• Datamonitor Oncology Reports
• Datamonitor Pharmavitae Reports
• Datamonitor Respiratory Reports
• Datamonitor Womens Health Reports

Contact us:
Editorial and features: peter.barfoot@bioportfolio.com 

Subscriber information:
To subscribe for the BioPortfolio Bulletin in HTML, email:
bioportfolio-subscribe-request@peach.ease.lsoft.com

To unsubscribe, email: bioportfolio-signoff-request@peach.ease.lsoft.com WITH NO SUBJECT.  The system will automatically remove your email address from the list based on your email address.  If your email has changed please email support@bioportfolio.com with a list of your email address and we will manually unsubscribe for you.  Thank you for your understanding.

©2003 BioPortfolio Limited